{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:20:21Z","timestamp":1791264021441,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,4,26]],"date-time":"2009-04-26T00:00:00Z","timestamp":1240704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,4,26]],"date-time":"2009-04-26T00:00:00Z","timestamp":1240704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/nm.1953","type":"journal-article","created":{"date-parts":[[2009,4,26]],"date-time":"2009-04-26T17:52:03Z","timestamp":1240768323000},"page":"528-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":207,"title":["Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies"],"prefix":"10.1038","volume":"15","author":[{"given":"Marc","family":"Pellegrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Calzascia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha R","family":"Elford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arda","family":"Shahinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilan","family":"Dissanayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Dhanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh T","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A","family":"Gronski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Morre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Assouline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Lahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Sparwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela S","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tak W","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,26]]},"reference":[{"key":"BFnm1953_CR1","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1158\/0008-5472.CAN-06-4626","volume":"67","author":"GC Prendergast","year":"2007","unstructured":"Prendergast, G.C. & Jaffee, E.M. Cancer immunologists and cancer biologists: why we didn't talk then but need to now. Cancer Res. 67, 3500\u20133504 (2007).","journal-title":"Cancer Res."},{"key":"BFnm1953_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/315115a0","volume":"315","author":"D Hanahan","year":"1985","unstructured":"Hanahan, D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes. Nature 315, 115\u2013122 (1985).","journal-title":"Nature"},{"key":"BFnm1953_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0092-8674(91)90164-T","volume":"65","author":"PS Ohashi","year":"1991","unstructured":"Ohashi, P.S. et al. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65, 305\u2013317 (1991).","journal-title":"Cell"},{"key":"BFnm1953_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1084\/jem.186.5.645","volume":"186","author":"DE Speiser","year":"1997","unstructured":"Speiser, D.E. et al. Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J. Exp. Med. 186, 645\u2013653 (1997).","journal-title":"J. Exp. Med."},{"key":"BFnm1953_CR5","doi-asserted-by":"publisher","first-page":"14175","DOI":"10.1073\/pnas.2336198100","volume":"100","author":"M Pellegrini","year":"2003","unstructured":"Pellegrini, M., Belz, G., Bouillet, P. & Strasser, A. Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc. Natl. Acad. Sci. USA 100, 14175\u201314180 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1953_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.it.2004.08.012","volume":"25","author":"A Strasser","year":"2004","unstructured":"Strasser, A. & Pellegrini, M. T-lymphocyte death during shutdown of an immune response. Trends Immunol. 25, 610\u2013615 (2004).","journal-title":"Trends Immunol."},{"key":"BFnm1953_CR7","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1172\/JCI200523134","volume":"115","author":"F Melchionda","year":"2005","unstructured":"Melchionda, F. et al. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J. Clin. Invest. 115, 1177\u20131187 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnm1953_CR8","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.4049\/jimmunol.178.7.4027","volume":"178","author":"P Tripathi","year":"2007","unstructured":"Tripathi, P., Mitchell, T.C., Finkelman, F. & Hildeman, D.A. Cutting edge: limiting amounts of IL-7 do not control contraction of CD4+ T cell responses. J. Immunol. 178, 4027\u20134031 (2007).","journal-title":"J. Immunol."},{"key":"BFnm1953_CR9","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1182\/blood.V99.11.3892","volume":"99","author":"TJ Fry","year":"2002","unstructured":"Fry, T.J. & Mackall, C.L. Interleukin-7: from bench to clinic. Blood 99, 3892\u20133904 (2002).","journal-title":"Blood"},{"key":"BFnm1953_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/01.cji.0000210386.55951.c2","volume":"29","author":"SA Rosenberg","year":"2006","unstructured":"Rosenberg, S.A. et al. IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J. Immunother. 29, 313\u2013319 (2006).","journal-title":"J. Immunother."},{"key":"BFnm1953_CR11","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1073\/pnas.89.9.3850","volume":"89","author":"T Aoki","year":"1992","unstructured":"Aoki, T. et al. Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo. Proc. Natl. Acad. Sci. USA 89, 3850\u20133854 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1953_CR12","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/eji.1830250831","volume":"25","author":"S Cayeux","year":"1995","unstructured":"Cayeux, S., Beck, C., Aicher, A., Dorken, B. & Blankenstein, T. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines. Eur. J. Immunol. 25, 2325\u20132331 (1995).","journal-title":"Eur. J. Immunol."},{"key":"BFnm1953_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1084\/jem.20050732","volume":"202","author":"L Gattinoni","year":"2005","unstructured":"Gattinoni, L. et al. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J. Exp. Med. 202, 907\u2013912 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnm1953_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/10430340050016157","volume":"11","author":"PW Miller","year":"2000","unstructured":"Miller, P.W. et al. Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication. Hum. Gene Ther. 11, 53\u201365 (2000).","journal-title":"Hum. Gene Ther."},{"key":"BFnm1953_CR15","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1182\/blood.V97.6.1525","volume":"97","author":"TJ Fry","year":"2001","unstructured":"Fry, T.J., Christensen, B.L., Komschlies, K.L., Gress, R.E. & Mackall, C.L. Interleukin-7 restores immunity in athymic T-cell\u2013depleted hosts. Blood 97, 1525\u20131533 (2001).","journal-title":"Blood"},{"key":"BFnm1953_CR16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O","volume":"28","author":"A Oxenius","year":"1998","unstructured":"Oxenius, A., Bachmann, M.F., Zinkernagel, R.M. & Hengartner, H. Virus-specific MHC-class II\u2013restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28, 390\u2013400 (1998).","journal-title":"Eur. J. Immunol."},{"key":"BFnm1953_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/342559a0","volume":"342","author":"H Pircher","year":"1989","unstructured":"Pircher, H., Burki, K., Lang, R., Hengartner, H. & Zinkernagel, R.M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342, 559\u2013561 (1989).","journal-title":"Nature"},{"key":"BFnm1953_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1084\/jem.179.1.31","volume":"179","author":"DH Lynch","year":"1994","unstructured":"Lynch, D.H. & Miller, R.E. Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo. J. Exp. Med. 179, 31\u201342 (1994).","journal-title":"J. Exp. Med."},{"key":"BFnm1953_CR19","first-page":"1027","volume":"118","author":"SG Nanjappa","year":"2008","unstructured":"Nanjappa, S.G., Walent, J.H., Morre, M. & Suresh, M. Effects of IL-7 on memory CD8 T cell homeostasis are influenced by the timing of therapy in mice. J. Clin. Invest. 118, 1027\u20131039 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnm1953_CR20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington, L.E. et al. Interleukin 17\u2013producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123\u20131132 (2005).","journal-title":"Nat. Immunol."},{"key":"BFnm1953_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233\u2013240 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnm1953_CR22","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133\u20131141 (2005).","journal-title":"Nat. Immunol."},{"key":"BFnm1953_CR23","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1084\/jem.20050085","volume":"201","author":"CR Ruprecht","year":"2005","unstructured":"Ruprecht, C.R. et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J. Exp. Med. 201, 1793\u20131803 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnm1953_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1600-065X.2006.00442.x","volume":"213","author":"TF Gajewski","year":"2006","unstructured":"Gajewski, T.F. et al. Immune resistance orchestrated by the tumor microenvironment. Immunol. Rev. 213, 131\u2013145 (2006).","journal-title":"Immunol. Rev."},{"key":"BFnm1953_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1084\/jem.20050930","volume":"203","author":"I Kryczek","year":"2006","unstructured":"Kryczek, I. et al. B7\u2013H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J. Exp. Med. 203, 871\u2013881 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnm1953_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1084\/jem.20060219","volume":"203","author":"N Martin-Orozco","year":"2006","unstructured":"Martin-Orozco, N. & Dong, C. New battlefields for costimulation. J. Exp. Med. 203, 817\u2013820 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnm1953_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrc1929","volume":"6","author":"AJ Muller","year":"2006","unstructured":"Muller, A.J. & Scherle, P.A. Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors. Nat. Rev. Cancer 6, 613\u2013625 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1953_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrc1586","volume":"5","author":"W Zou","year":"2005","unstructured":"Zou, W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5, 263\u2013274 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1953_CR29","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1172\/JCI0214685","volume":"109","author":"M Huang","year":"2002","unstructured":"Huang, M. et al. IL-7 inhibits fibroblast TGF-\u03b2 production and signaling in pulmonary fibrosis. J. Clin. Invest. 109, 931\u2013937 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnm1953_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2006.04.015","volume":"25","author":"TR Mempel","year":"2006","unstructured":"Mempel, T.R. et al. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25, 129\u2013141 (2006).","journal-title":"Immunity"},{"key":"BFnm1953_CR31","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/ni1398","volume":"7","author":"L Li","year":"2006","unstructured":"Li, L., Iwamoto, Y., Berezovskaya, A. & Boussiotis, V.A. A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nat. Immunol. 7, 1157\u20131165 (2006).","journal-title":"Nat. Immunol."},{"key":"BFnm1953_CR32","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S1097-2765(00)00134-9","volume":"6","author":"P Kavsak","year":"2000","unstructured":"Kavsak, P. et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF \u03b2 receptor for degradation. Mol. Cell 6, 1365\u20131375 (2000).","journal-title":"Mol. Cell"},{"key":"BFnm1953_CR33","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1073\/pnas.98.3.974","volume":"98","author":"Y Zhang","year":"2001","unstructured":"Zhang, Y., Chang, C., Gehling, D.J., Hemmati-Brivanlou, A. & Derynck, R. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc. Natl. Acad. Sci. USA 98, 974\u2013979 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1953_CR34","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.4049\/jimmunol.176.3.1316","volume":"176","author":"EA Wohlfert","year":"2006","unstructured":"Wohlfert, E.A., Gorelik, L., Mittler, R., Flavell, R.A. & Clark, R.B. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-\u03b2 sensitivity in vitro and in vivo. J. Immunol. 176, 1316\u20131320 (2006).","journal-title":"J. Immunol."},{"key":"BFnm1953_CR35","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.4049\/jimmunol.173.2.1059","volume":"173","author":"EA Wohlfert","year":"2004","unstructured":"Wohlfert, E.A., Callahan, M.K. & Clark, R.B. Resistance to CD4+CD25+ regulatory T cells and TGF-\u03b2 in Cbl-b\u2212\/\u2212 mice. J. Immunol. 173, 1059\u20131065 (2004).","journal-title":"J. Immunol."},{"key":"BFnm1953_CR36","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/ni.1670","volume":"9","author":"B Yang","year":"2008","unstructured":"Yang, B. et al. Nedd4 augments the adaptive immune response by promoting ubiquitin-mediated degradation of Cbl-b in activated T cells. Nat. Immunol. 9, 1356\u20131363 (2008).","journal-title":"Nat. Immunol."},{"key":"BFnm1953_CR37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","volume":"112","author":"P Muranski","year":"2008","unstructured":"Muranski, P. et al. Tumor-specific TH17-polarized cells eradicate large established melanoma. Blood 112, 362\u2013373 (2008).","journal-title":"Blood"},{"key":"BFnm1953_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1084\/jem.20061852","volume":"204","author":"K Lahl","year":"2007","unstructured":"Lahl, K. et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204, 57\u201363 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnm1953_CR39","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1084\/jem.20061699","volume":"204","author":"S Loeser","year":"2007","unstructured":"Loeser, S. et al. Spontaneous tumor rejection by cbl-b\u2013deficient CD8+ T cells. J. Exp. Med. 204, 879\u2013891 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnm1953_CR40","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1172\/JCI29472","volume":"117","author":"JY Chiang","year":"2007","unstructured":"Chiang, J.Y., Jang, I.K., Hodes, R. & Gu, H. Ablation of Cbl-b provides protection against transplanted and spontaneous tumors. J. Clin. Invest. 117, 1029\u20131036 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnm1953_CR41","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/intimm\/dxm093","volume":"19","author":"S Liu","year":"2007","unstructured":"Liu, S. et al. IL-21 synergizes with IL-7 to augment expansion and anti-tumor function of cytotoxic T cells. Int. Immunol. 19, 1213\u20131221 (2007).","journal-title":"Int. Immunol."},{"key":"BFnm1953_CR42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature06878","volume":"453","author":"L Zhou","year":"2008","unstructured":"Zhou, L. et al. TGF-\u03b2\u2013induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORgammat function. Nature 453, 236\u2013240 (2008).","journal-title":"Nature"},{"key":"BFnm1953_CR43","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.immuni.2008.07.018","volume":"29","author":"H Ogura","year":"2008","unstructured":"Ogura, H. et al. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29, 628\u2013636 (2008).","journal-title":"Immunity"},{"key":"BFnm1953_CR44","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nm1449","volume":"12","author":"CG King","year":"2006","unstructured":"King, C.G. et al. TRAF6 is a T cell\u2013intrinsic negative regulator required for the maintenance of immune homeostasis. Nat. Med. 12, 1088\u20131092 (2006).","journal-title":"Nat. Med."},{"key":"BFnm1953_CR45","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/ni1106","volume":"5","author":"DL Mueller","year":"2004","unstructured":"Mueller, D.L. E3 ubiquitin ligases as T cell anergy factors. Nat. Immunol. 5, 883\u2013890 (2004).","journal-title":"Nat. Immunol."},{"key":"BFnm1953_CR46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ni763","volume":"3","author":"D Fang","year":"2002","unstructured":"Fang, D. et al. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nat. Immunol. 3, 281\u2013287 (2002).","journal-title":"Nat. Immunol."},{"key":"BFnm1953_CR47","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.coi.2007.10.002","volume":"19","author":"AE Lin","year":"2007","unstructured":"Lin, A.E. & Mak, T.W. The role of E3 ligases in autoimmunity and the regulation of autoreactive T cells. Curr. Opin. Immunol. 19, 665\u2013673 (2007).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnm1953_CR48","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.molcel.2004.07.021","volume":"15","author":"Y Bai","year":"2004","unstructured":"Bai, Y., Yang, C., Hu, K., Elly, C. & Liu, Y.C. Itch E3 ligase-mediated regulation of TGF-\u03b2 signaling by modulating smad2 phosphorylation. Mol. Cell 15, 825\u2013831 (2004).","journal-title":"Mol. Cell"},{"key":"BFnm1953_CR49","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/35003228","volume":"403","author":"K Bachmaier","year":"2000","unstructured":"Bachmaier, K. et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403, 211\u2013216 (2000).","journal-title":"Nature"},{"key":"BFnm1953_CR50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/35003235","volume":"403","author":"YJ Chiang","year":"2000","unstructured":"Chiang, Y.J. et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403, 216\u2013220 (2000).","journal-title":"Nature"},{"key":"BFnm1953_CR51","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/nm1114","volume":"10","author":"MA Gronski","year":"2004","unstructured":"Gronski, M.A. et al. TCR affinity and negative regulation limit autoimmunity. Nat. Med. 10, 1234\u20131239 (2004).","journal-title":"Nat. Med."},{"key":"BFnm1953_CR52","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1076514","volume":"298","author":"ME Dudley","year":"2002","unstructured":"Dudley, M.E. et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298, 850\u2013854 (2002).","journal-title":"Science"},{"key":"BFnm1953_CR53","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1200\/JCO.2008.16.5449","volume":"26","author":"ME Dudley","year":"2008","unstructured":"Dudley, M.E. et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J. Clin. Oncol. 26, 5233\u20135239 (2008).","journal-title":"J. Clin. Oncol."},{"key":"BFnm1953_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.it.2008.02.003","volume":"29","author":"M Bellone","year":"2008","unstructured":"Bellone, M., Mondino, A. & Corti, A. Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer. Trends Immunol. 29, 235\u2013241 (2008).","journal-title":"Trends Immunol."},{"key":"BFnm1953_CR55","first-page":"3833","volume":"117","author":"T Calzascia","year":"2007","unstructured":"Calzascia, T. et al. TNF-\u03b1 is critical for antitumor but not antiviral T cell immunity in mice. J. Clin. Invest. 117, 3833\u20133845 (2007).","journal-title":"J. Clin. Invest."}],"updated-by":[{"DOI":"10.1038\/nm0709-819b","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm.1953.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.1953","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.1953.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T06:08:56Z","timestamp":1744351736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.1953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,26]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BFnm1953"],"URL":"https:\/\/doi.org\/10.1038\/nm.1953","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/nm0709-819b","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,26]]},"assertion":[{"value":"9 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2009","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Corrigendum","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, the two right histological sections in Figure 5a were duplicated in Figure 5b. The error has been corrected in the HTML and PDF versions of the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.M. is the founder and chief executive officer and B.A. is an employee of Cytheris; both M.M. and B.A. have financial interest in its capital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}